Heart Failure Risk Reduction in Diabetes: What the Practicing Endocrinologist Should Know

Dr Jennifer Green on why to be vigilant in assessing for HF in patients with T2D, and the evolving use of SGLT2 inhibitors in these patients, from Clinical Care Options (CCO)

Jennifer B. Green, MD Released: June 22, 2021

Type 2 diabetes management: Dr. Veronica K. Piziak on NPH, regular insulin, switching to avoid hypoglycemia/reduce CV risk in T2DM

Veronica K. Piziak, MD, PhD, FACP
Program Director Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Released: January 11, 2019 Expired: No longer available for credit

Type 2 diabetes management: Dr. Veronica K. Piziak on NPH, regular insulin, switching to avoid hypoglycemia/reduce CV risk in T2DM

Veronica K. Piziak, MD, PhD, FACP
Program Director Released: December 10, 2018

T2DM and CV risk management. Guillermo Umpierrez on choosing A1C and using guidelines/algorithms for metformin, SUs, TZDs, DPP-4s, SGLT2s

Guillermo E. Umpierrez, MD, CDE Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Released: December 5, 2018 Expired: No longer available for credit